Fig. 1: Kaplan Meier curves for time to next treatment (TTNT) based on MRD status. | Blood Cancer Journal

Fig. 1: Kaplan Meier curves for time to next treatment (TTNT) based on MRD status.

From: Integrated analysis of next generation sequencing minimal residual disease (MRD) and PET scan in transplant eligible myeloma patients

Fig. 1

Based on MRD status at Day 100 Post-ASCT evaluation. A The median TTNT was not reached for those patients who achieved negativity at 10−6; and was 60.5 months for patients who remained positive. B The median TTNT was not reached for reached for patients who achieved MRD negativity at 10-6, 59.1 months in those who achieved negativity at 10−5, and 61 months who remained MRD positive.

Back to article page